ReviewFrontiers in genetics2019

Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease Progression.

Koji Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.